Skip to Main content Skip to Navigation
Journal articles

Genomic diversity contributes to the neuroinvasiveness of the Yellow fever French neurotropic vaccine

Abstract : Mass vaccination with the live attenuated vaccine YF-17D is the current way to prevent infection with Yellow fever virus (YFV). However, 0.000012-0.00002% of vaccinated patients develop post-vaccination neurological syndrome (YEL-AND). Understanding the factors responsible for neuroinvasion, neurotropism, and neurovirulence of the vaccine is critical for improving its biosafety. The YF-FNV vaccine strain, known to be associated with a higher frequency of YEL-AND (0.3-0.4%) than YF-17D, is an excellent model to study vaccine neuroinvasiveness. We determined that neuroinvasiveness of YF-FNV occured both via infection and passage through human brain endothelial cells. Plaque purification and next generation sequencing (NGS) identified several neuroinvasive variants. Their neuroinvasiveness was not higher than that of YF-FNV. However, rebuilding the YF-FNV population diversity from a set of isolated YF-FNV-N variants restored the original neuroinvasive phenotype of YF-FNV. Therefore, we conclude that viral population diversity is a critical factor for YFV vaccine neuroinvasiveness.
Document type :
Journal articles
Complete list of metadata

https://hal.sorbonne-universite.fr/hal-03213234
Contributor : Gestionnaire Hal-Su <>
Submitted on : Friday, April 30, 2021 - 11:47:59 AM
Last modification on : Thursday, May 6, 2021 - 10:53:23 AM

File

s41541-021-00318-3.pdf
Publication funded by an institution

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Citation

Florian Bakoa, Christophe Préhaud, Guillaume Beauclair, Maxime Chazal, Nathalie Mantel, et al.. Genomic diversity contributes to the neuroinvasiveness of the Yellow fever French neurotropic vaccine. NPJ vaccines, Nature Research 2021, 6 (1), pp.64. ⟨10.1038/s41541-021-00318-3⟩. ⟨hal-03213234⟩

Share

Metrics

Record views

66

Files downloads

51